| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 23,675 | 22,646 | 18,183 | 36,795 | | Cost of Revenue | 13,385 | 12,860 | 10,288 | 23,593 | | | Gross Profit | 10,290 | 9,786 | 7,895 | 13,202 | | | Operating Expenses | | Research Development | 8,850 | 8,642 | 9,091 | 9,602 | | Selling General and Administrative | 8,996 | 9,741 | 9,509 | 9,961 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (7,556) | (8,597) | (10,705) | (6,361) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (91) | (377) | 310 | 606 | | Earnings Before Interest And Taxes | (7,647) | (8,974) | (10,395) | (5,755) | | Interest Expense | 415 | 419 | 425 | 430 | | Income Before Tax | (8,062) | (9,393) | (10,820) | (6,185) | | Income Tax Expense | 155 | 131 | (255) | 67 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (8,217) | (9,524) | (10,565) | (6,252) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (8,217) | (9,524) | (10,565) | (6,252) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($8,217) | ($9,524) | ($10,565) | ($6,252) |
|
0.01% Nasdaq 0.00%
Income Statement
